News

UNAIDS Executive Director: ‘The HIV Response Is in Crisis’
Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...
FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag
Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...
ConsumerAffairs4h
FDA approves twice-yearly injection for HIV prevention
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
Stocktwits on MSN13h
Gilead Earns Analyst Praise As FDA Clears Yeztugo For Biannual HIV Prevention
Gilead Sciences garnered investor and analyst focus after the U.S. FDA approval of Yeztugo, or lenacapavir, the company’s ...
Managed Healthcare Executive14h
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Mother Jones18h
FDA Approves “Breakthrough” HIV Drug
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
FDA Approves New Injection For HIV Prevention
The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...
Zimbabwe Situation19h
Twice-a-year shot to prevent HIV could stop transmission — if people can get it
Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...
Queerty20h
FDA approves world’s first twice-yearly PrEP injection
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Rolling Out23h
99.9% breakthrough transforms HIV prevention forever
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...